Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Flaws

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Health Facilities Management|June 7, 1992
Health care construction. Which architect should you pick?J A Flaws
Experimental Biology and Medicine (Maywood, N.J.)|September 12, 2003
How does the absence of both p53 and FasL affect development and reproduction?J A Flaws
Medical Hypotheses|August 5, 1998
Racial differences in drug metabolism: an explanation for higher breast cancer mortality in blacks?J A Flaws, T L Bush
Biology of Reproduction|May 1, 1993
Preparation of an enriched fraction of luteinizing hormone-secreting cells from a mixed population of rat anterior pituitary cellsJ A Flaws, D E Suter
Journal of Women'S Health|April 1, 1999
Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal periodE K Silbergeld, J A Flaws
Reproductive Toxicology (Elmsford, N.Y.)|May 7, 2019
Retinoic acid signaling in ovarian folliculogenesis and steroidogenesisP Damdimopoulou, C Chiang, J A Flaws
Obstetrics and Gynecology|September 1, 2001
Hormone replacement therapy and breast cancer: a qualitative reviewT L Bush, M Whiteman, J A Flaws
Frontiers in Bioscience : a Journal and Virtual Library|August 6, 2002
The effects of endocrine disrupting chemicals on the ovaryC Borgeest, C Greenfeld, D Tomic, et al.
Journal of Women'S Health|February 4, 1999
SERMs: the benefits of estrogen without the risks?R C Cole, J A Flaws, T L Bush
The New England Journal of Medicine|July 11, 1998
Effects of raloxifene in postmenopausal womenR C Cole, J A Flaws, T L Bush
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Health Facilities Management|June 7, 1992
Health care construction. Which architect should you pick?J A Flaws
Experimental Biology and Medicine (Maywood, N.J.)|September 12, 2003
How does the absence of both p53 and FasL affect development and reproduction?J A Flaws
Medical Hypotheses|August 5, 1998
Racial differences in drug metabolism: an explanation for higher breast cancer mortality in blacks?J A Flaws, T L Bush
Biology of Reproduction|May 1, 1993
Preparation of an enriched fraction of luteinizing hormone-secreting cells from a mixed population of rat anterior pituitary cellsJ A Flaws, D E Suter
Journal of Women'S Health|April 1, 1999
Chemicals and menopause: effects on age at menopause and on health status in the postmenopausal periodE K Silbergeld, J A Flaws
Reproductive Toxicology (Elmsford, N.Y.)|May 7, 2019
Retinoic acid signaling in ovarian folliculogenesis and steroidogenesisP Damdimopoulou, C Chiang, J A Flaws
Obstetrics and Gynecology|September 1, 2001
Hormone replacement therapy and breast cancer: a qualitative reviewT L Bush, M Whiteman, J A Flaws
Frontiers in Bioscience : a Journal and Virtual Library|August 6, 2002
The effects of endocrine disrupting chemicals on the ovaryC Borgeest, C Greenfeld, D Tomic, et al.
Journal of Women'S Health|February 4, 1999
SERMs: the benefits of estrogen without the risks?R C Cole, J A Flaws, T L Bush
The New England Journal of Medicine|July 11, 1998
Effects of raloxifene in postmenopausal womenR C Cole, J A Flaws, T L Bush
Pageof 6